peptide elongation factor 2 has been researched along with thiazoles in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kohno, K; Miyagawa, K; Nobukuni, Y | 1 |
1 other study(ies) available for peptide elongation factor 2 and thiazoles
| Article | Year |
|---|---|
Gene trap mutagenesis-based forward genetic approach reveals that the tumor suppressor OVCA1 is a component of the biosynthetic pathway of diphthamide on elongation factor 2.
Topics: Adenosine Diphosphate; Animals; Base Sequence; Blotting, Southern; Blotting, Western; CHO Cells; Coloring Agents; Cricetinae; Diphtheria Toxin; DNA, Complementary; Dose-Response Relationship, Drug; Genes, Tumor Suppressor; Genetic Techniques; Histidine; Humans; Mice; Minor Histocompatibility Antigens; Molecular Sequence Data; Mutagenesis; Mutation; Peptide Elongation Factor 2; Phenotype; Plasmids; Polymerase Chain Reaction; Proteins; Retroviridae; Sequence Homology, Nucleic Acid; Tetrazolium Salts; Thiazoles; Toxins, Biological; Tumor Suppressor Proteins | 2005 |